The Challenge
An InFocus Clinical Research partner facing a long clinical development pathway of a sensitive, costly, biotechnology product was concerned about a multitude of parameters critical to program and protocol planning – the existence of a focused population of subjects, the ability of sites to identify subjects and the capability of myriad sites to execute a complex, cross-functional clinical study. Any mistake in the forecasting of subject availability, sites targeted to execute the study or selecting dormant or dull sites would cost the sponsor tens of millions of dollars and several years of development delays.
The Solution
The sponsor recognized the unique, unprecedented value that – for ophthalmology clinical development programs – only InFocus Clinical Research can provide. Several critical, proprietary InFocus Clinical Research services and organic offerings were utilized, including:
- Proprietary 2 million+ longitudinal retina patient database
- Proprietary network of >110 Americas (North, Central, South) and >120 EU ophthalmology research sites
- Scientific Advisory Board of leading ophthalmology and retina specialty KOLs
- Decades of forged relationships with the world’s foremost ophthalmology and retina specialty clinical development leaders and champions
- Global staff and resources with decades of industry and retina specialty experience, knowledgeable of historical and current trends and insights
The Choice
Simply, there is no Contract Research Organization more engaged in the development of retina specialty products and therapeutics than InFocus Clinical Research. There is no CRO with the global network, resources and capabilities to drive retina specialty programs with the precision, quality and efficiency offered by InFocus Clinical Research. InFocus Clinical Research is the premier provider of ophthalmology and retina specialty CRO services and, thus, the choice is simple for, especially, costly and sensitive clinical development programs
The Results
InFocus was able to draw upon its patient database, SAB, site network and real time intelligence network to forge the most efficient, quality pathway for this product.
Sample data outputs that are valuable to sponsors developing programs and protocols:
